|
1
|
Minniti G, De Sanctis V, Muni R, Filippone
F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G,
Tombolini V and Maurizi Enrici R: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma in elderly patients. J
Neurooncol. 88:97–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakada M, Nakada S, Demuth T, Tran NL,
Hoelzinger DB and Berens ME: Molecular targets of glioma invasion.
Cell Mol Life Sci. 64:458–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bürglin TR: Analysis of TALE superclass
homeobox genes (MEIS, PBC, KNOX, Iroquois, TGIF) reveals a novel
domain conserved between plants and animals. Nucleic Acids Res.
25:4173–4180. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Doi T, Lukošiūtė A, Ruttenstock E,
Dingemann J and Puri P: Expression of Iroquois genes is
up-regulated during early lung development in the nitrofen-induced
pulmonary hypoplasia. J Pediatr Surg. 46:62–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang PX, Yang HW, Wang X, Wang L, Cheng
YD, Zhang YS, et al: The genomic organization and function of IRX1
in tumorigenesis and development. Cancer Transl Med. 3:29–33. 2017.
View Article : Google Scholar
|
|
6
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32106. View Article : Google Scholar
|
|
7
|
Torsvik A, Stieber D, Enger PØ,
Golebiewska A, Molven A, Svendsen A, Westermark B, Niclou SP, Olsen
TK, Chekenya Enger M and Bjerkvig R: U-251 revisited: genetic drift
and phenotypic consequences of long-term cultures of glioblastoma
cells. Cancer Med. 3:812–824. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang HJ, Yu S, Wang J, Chen C, Gu Y and
Bao XY: Expression and clinical significance of Iroquois homebox
gene IRX1 in human hepatocellular carcinoma cells. Chin J
Biologicals. 25:1354–1357. 2010.(In Chinese).
|
|
10
|
Lu J, Song G, Tang Q, Zou C, Han F, Zhao
Z, Yin J, Xu H, Xie X, et al: IRX1 hypomethylation promotes
osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. J
Clin Invest. 25:1839–1856. 2015. View
Article : Google Scholar
|
|
11
|
Guo X, Liu W, Pan Y, Ni P, Ji J, Guo L,
Zhang J, Wu J, Jiang J, Chen X, et al: Homeobox gene IRX1 is a
tumor suppressor gene in gastric carcinoma. Oncogene. 29:3908–3920.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang J, Liu W, Guo X, Zhang R, Zhi Q, Ji
J, et al: IRX1 influences peritoneal spreading and metastasis via
inhibiting BDKRB2-dependent neovascularization on gastric cancer.
Oncogene. 30:4498–4508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bennett KL, Karpenko M, Lin MT, Claus R,
Arab K, Dyckhoff G, Plinkert P, Herpel E, Smiraglia D and Plass C:
Frequently methylated tumor suppressor genes in head and neck
squamous cell carcinoma. Cancer Res. 68:4494–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei W, Xu L, Wang F, He SS, Yang LJ, Guo
CY and Wang XP: Expression and methylation of Iroquois homeobox
protein 1 in pancreatic cancer. Chin J Pancreat. 11:309–311.
2011.
|
|
15
|
Kühn A, Löscher D and Marschalek R: The
IRX1/HOXA connection: insights into a novel t(4;11)-specific cancer
mechanism. Oncotarget. 7:35341–35352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng YD, Tu YY and Liang P: Promoter
Methylated Tumor Suppressor Genes in Glioma. Cancer Transl Med.
1:123–130. 2015. View Article : Google Scholar
|
|
17
|
Cadieux B, Ching TT, VandenBerg SR and
Costello JF: Genome-wide hypomethylation in human glioblastomas
associated with specific copy number alteration,
methylenetetrahydrofolate reductase allele status, and increased
proliferation. Cancer Res. 66:8469–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ting AH, McGarvey KM and Baylin SB: The
cancer epigenome-components and functional correlates. Genes Dev.
20:3215–3231. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Frigola J, Solé X, Paz MF, Moreno V,
Esteller M, Capellà G and Peinado MA: Differential DNA
hypermethylation and hypomethylation signatures in colorectal
cancer. Hum Mol Genet. 14:319–326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ehrlich M, Jiang G, Fiala E, Dome JS, Yu
MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, et al:
Hypomethylation and hypermethylation of DNA in Wilms tumors.
Oncogene. 21:6694–6702. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu N and Tu YY: Systematic Review of
MicroRNAs and its Therapeutic Potential in Glioma. Cancer Transl
Med. 1:50–66. 2015. View Article : Google Scholar
|
